Build Your Comparison

Side-by-side financial analysis
WAY logo
WAY
UNH logo
UNH
Try popular comparisons:

Stock Comparison

WAY vs UNH

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
WAY
Waystar Holding Corp.

Information Technology Services

TechnologyNASDAQ • US
Market Cap$3.60B
5Y Perf.-12.8%
UNH
UnitedHealth Group Incorporated

Medical - Healthcare Plans

HealthcareNYSE • US
Market Cap$370.80B
5Y Perf.-19.8%

WAY vs UNH — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
WAY logoWAY
UNH logoUNH
IndustryInformation Technology ServicesMedical - Healthcare Plans
Market Cap$3.60B$370.80B
Revenue (TTM)$1.16B$449.71B
Net Income (TTM)$126M$12.04B
Gross Margin65.2%18.8%
Operating Margin24.3%4.2%
Forward P/E11.4x22.2x
Total Debt$1.50B$78.39B
Cash & Equiv.$61M$24.36B

WAY vs UNHLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

WAY
UNH
StockJun 24Jun 26Return
Waystar Holding Cor… (WAY)10087.2-12.8%
UnitedHealth Group … (UNH)10080.2-19.8%

Price return only. Dividends and distributions are not included.

Quick Verdict: WAY vs UNH

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: UNH leads in 4 of 7 categories, making it the strongest pick for capital preservation and lower volatility and dividend income and shareholder returns. Waystar Holding Corp. is the stronger pick specifically for growth and revenue expansion and valuation and capital efficiency. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
🥇UNH emerged as the overall leader. Track its performance:
WAY
Waystar Holding Corp.
The Growth Play

WAY is the clearest fit if your priority is growth exposure and sleep-well-at-night.

  • Rev growth 16.5%, EPS growth 5.7%, 3Y rev CAGR 16.0%
  • Lower volatility, beta 0.84, Low D/E 38.7%, current ratio 1.41x
  • 16.5% revenue growth vs UNH's 11.8%
Best for: growth exposure and sleep-well-at-night
UNH
UnitedHealth Group Incorporated
The Insurance Pick

UNH carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.

  • Dividend streak 16 yrs, beta 0.61, yield 2.1%
  • 236.1% 10Y total return vs WAY's -9.4%
  • Beta 0.61, yield 2.1%, current ratio 0.79x
Best for: income & stability and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthWAY logoWAY16.5% revenue growth vs UNH's 11.8%
ValueWAY logoWAYLower P/E (11.4x vs 22.2x)
Quality / MarginsWAY logoWAY10.9% margin vs UNH's 2.7%
Stability / SafetyUNH logoUNHBeta 0.61 vs WAY's 0.84
DividendsUNH logoUNH2.1% yield; 16-year raise streak; the other pay no meaningful dividend
Momentum (1Y)UNH logoUNH+31.0% vs WAY's -52.6%
Efficiency (ROA)UNH logoUNH3.9% ROA vs WAY's 2.4%, ROIC 9.2% vs 4.2%

WAY vs UNH — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

Discover the Biotech & Healthcare Stocks Theme

These companies are key players in the Biotech & Healthcare Stocks ecosystem. See how they stack up against the rest of the sector.

Explore Theme
WAYWaystar Holding Corp.
FY 2025
Subscription and Circulation
100.0%$558M
UNHUnitedHealth Group Incorporated
FY 2025
Unitedhealthcare
94.4%$332.4B
Optumhealth
5.6%$19.8B

WAY vs UNH — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLUNHLAGGINGWAY

Income & Cash Flow (Last 12 Months)

WAY leads this category, winning 6 of 6 comparable metrics.

UNH is the larger business by revenue, generating $449.7B annually — 388.8x WAY's $1.2B. WAY is the more profitable business, keeping 10.9% of every revenue dollar as net income compared to UNH's 2.7%. On growth, WAY holds the edge at +22.4% YoY revenue growth, suggesting stronger near-term business momentum.

MetricWAY logoWAYWaystar Holding C…UNH logoUNHUnitedHealth Grou…
RevenueTrailing 12 months$1.2B$449.7B
EBITDAEarnings before interest/tax$430M$23.2B
Net IncomeAfter-tax profit$126M$12.0B
Free Cash FlowCash after capex$294M$19.7B
Gross MarginGross profit ÷ Revenue+65.2%+18.8%
Operating MarginEBIT ÷ Revenue+24.3%+4.2%
Net MarginNet income ÷ Revenue+10.9%+2.7%
FCF MarginFCF ÷ Revenue+25.4%+4.4%
Rev. Growth (YoY)Latest quarter vs prior year+22.4%+2.0%
EPS Growth (YoY)Latest quarter vs prior year+37.5%+0.7%
WAY leads this category, winning 6 of 6 comparable metrics.

Valuation Metrics

WAY leads this category, winning 5 of 6 comparable metrics.

At 30.7x trailing earnings, WAY trades at a 0% valuation discount to UNH's 30.9x P/E. On an enterprise value basis, WAY's 12.4x EV/EBITDA is more attractive than UNH's 18.2x.

MetricWAY logoWAYWaystar Holding C…UNH logoUNHUnitedHealth Grou…
Market CapShares × price$3.6B$370.8B
Enterprise ValueMkt cap + debt − cash$5.0B$424.8B
Trailing P/EPrice ÷ TTM EPS30.74x30.88x
Forward P/EPrice ÷ next-FY EPS est.11.42x22.21x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple12.39x18.21x
Price / SalesMarket cap ÷ Revenue3.27x0.83x
Price / BookPrice ÷ Book value/share0.95x3.66x
Price / FCFMarket cap ÷ FCF12.70x23.07x
WAY leads this category, winning 5 of 6 comparable metrics.

Profitability & Efficiency

UNH leads this category, winning 6 of 9 comparable metrics.

UNH delivers a 11.5% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $4 for WAY. WAY carries lower financial leverage with a 0.39x debt-to-equity ratio, signaling a more conservative balance sheet compared to UNH's 0.77x. On the Piotroski fundamental quality scale (0–9), UNH scores 6/9 vs WAY's 5/9, reflecting solid financial health.

MetricWAY logoWAYWaystar Holding C…UNH logoUNHUnitedHealth Grou…
ROE (TTM)Return on equity+3.5%+11.5%
ROA (TTM)Return on assets+2.4%+3.9%
ROICReturn on invested capital+4.2%+9.2%
ROCEReturn on capital employed+5.2%+9.7%
Piotroski ScoreFundamental quality 0–956
Debt / EquityFinancial leverage0.39x0.77x
Net DebtTotal debt minus cash$1.4B$54.0B
Cash & Equiv.Liquid assets$61M$24.4B
Total DebtShort + long-term debt$1.5B$78.4B
Interest CoverageEBIT ÷ Interest expense3.51x4.71x
UNH leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

UNH leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in UNH five years ago would be worth $11,165 today (with dividends reinvested), compared to $9,058 for WAY. Over the past 12 months, UNH leads with a +31.0% total return vs WAY's -52.6%. The 3-year compound annual growth rate (CAGR) favors WAY at -3.2% vs UNH's -4.2% — a key indicator of consistent wealth creation.

MetricWAY logoWAYWaystar Holding C…UNH logoUNHUnitedHealth Grou…
YTD ReturnYear-to-date-40.2%+22.1%
1-Year ReturnPast 12 months-52.6%+31.0%
3-Year ReturnCumulative with dividends-9.4%-12.0%
5-Year ReturnCumulative with dividends-9.4%+11.7%
10-Year ReturnCumulative with dividends-9.4%+236.1%
CAGR (3Y)Annualised 3-year return-3.2%-4.2%
UNH leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

UNH leads this category, winning 2 of 2 comparable metrics.

UNH is the less volatile stock with a 0.61 beta — it tends to amplify market swings less than WAY's 0.84 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. UNH currently trades 98.2% from its 52-week high vs WAY's 45.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricWAY logoWAYWaystar Holding C…UNH logoUNHUnitedHealth Grou…
Beta (5Y)Sensitivity to S&P 5000.84x0.61x
52-Week HighHighest price in past year$41.47$415.96
52-Week LowLowest price in past year$17.89$234.60
% of 52W HighCurrent price vs 52-week peak+45.2%+98.2%
RSI (14)Momentum oscillator 0–10040.366.5
Avg Volume (50D)Average daily shares traded2.4M7.2M
UNH leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Wall Street rates WAY as "Buy" and UNH as "Buy". Consensus price targets imply 90.0% upside for WAY (target: $36) vs 2.4% for UNH (target: $419). UNH is the only dividend payer here at 2.13% yield — a key consideration for income-focused portfolios.

MetricWAY logoWAYWaystar Holding C…UNH logoUNHUnitedHealth Grou…
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$35.62$418.50
# AnalystsCovering analysts1752
Dividend YieldAnnual dividend ÷ price+2.1%
Dividend StreakConsecutive years of raises16
Dividend / ShareAnnual DPS$8.70
Buyback YieldShare repurchases ÷ mkt cap0.0%+1.5%
Insufficient data to determine a leader in this category.
Key Takeaway

UNH leads in 3 of 6 categories (Profitability & Efficiency, Total Returns). WAY leads in 2 (Income & Cash Flow, Valuation Metrics).

Best OverallUnitedHealth Group Incorpor… (UNH)Leads 3 of 6 categories
Loading custom metrics...

WAY vs UNH: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is WAY or UNH a better buy right now?

For growth investors, Waystar Holding Corp.

(WAY) is the stronger pick with 16. 5% revenue growth year-over-year, versus 11. 8% for UnitedHealth Group Incorporated (UNH). Waystar Holding Corp. (WAY) offers the better valuation at 30. 7x trailing P/E (11. 4x forward), making it the more compelling value choice. Analysts rate Waystar Holding Corp. (WAY) a "Buy" — based on 17 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — WAY or UNH?

On trailing P/E, Waystar Holding Corp.

(WAY) is the cheapest at 30. 7x versus UnitedHealth Group Incorporated at 30. 9x. On forward P/E, Waystar Holding Corp. is actually cheaper at 11. 4x.

03

Which is the better long-term investment — WAY or UNH?

Over the past 5 years, UnitedHealth Group Incorporated (UNH) delivered a total return of +11.

7%, compared to -9. 4% for Waystar Holding Corp. (WAY). Over 10 years, the gap is even starker: UNH returned +236. 1% versus WAY's -9. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — WAY or UNH?

By beta (market sensitivity over 5 years), UnitedHealth Group Incorporated (UNH) is the lower-risk stock at 0.

61β versus Waystar Holding Corp. 's 0. 84β — meaning WAY is approximately 37% more volatile than UNH relative to the S&P 500. On balance sheet safety, Waystar Holding Corp. (WAY) carries a lower debt/equity ratio of 39% versus 77% for UnitedHealth Group Incorporated — giving it more financial flexibility in a downturn.

05

Which is growing faster — WAY or UNH?

By revenue growth (latest reported year), Waystar Holding Corp.

(WAY) is pulling ahead at 16. 5% versus 11. 8% for UnitedHealth Group Incorporated (UNH). On earnings-per-share growth, the picture is similar: Waystar Holding Corp. grew EPS 569. 2% year-over-year, compared to -14. 7% for UnitedHealth Group Incorporated. Over a 3-year CAGR, WAY leads at 16. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — WAY or UNH?

Waystar Holding Corp.

(WAY) is the more profitable company, earning 10. 2% net margin versus 2. 7% for UnitedHealth Group Incorporated — meaning it keeps 10. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: WAY leads at 24. 2% versus 4. 2% for UNH. At the gross margin level — before operating expenses — WAY leads at 64. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is WAY or UNH more undervalued right now?

On forward earnings alone, Waystar Holding Corp.

(WAY) trades at 11. 4x forward P/E versus 22. 2x for UnitedHealth Group Incorporated — 10. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for WAY: 90. 0% to $35. 62.

08

Which pays a better dividend — WAY or UNH?

In this comparison, UNH (2.

1% yield) pays a dividend. WAY does not pay a meaningful dividend and should not be held primarily for income.

09

Is WAY or UNH better for a retirement portfolio?

For long-horizon retirement investors, UnitedHealth Group Incorporated (UNH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

61), 2. 1% yield, +236. 1% 10Y return). Both have compounded well over 10 years (UNH: +236. 1%, WAY: -9. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between WAY and UNH?

These companies operate in different sectors (WAY (Technology) and UNH (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: WAY is a small-cap high-growth stock; UNH is a large-cap quality compounder stock. UNH pays a dividend while WAY does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.